Literature DB >> 1728310

VH gene rearrangement events can modify the immunoglobulin heavy chain during progression of B-lineage acute lymphoblastic leukemia.

R Wasserman1, M Yamada, Y Ito, L R Finger, B A Reichard, S Shane, B Lange, G Rovera.   

Abstract

The presence of multiple VHDJH joinings in upwards of 30% of acute lymphoblastic leukemias (ALL) suggests a relative instability of the rearranged immunoglobulin heavy chain (IgH) gene, but the mechanisms involved are not completely understood. An investigation of the structure of the VHDJH joinings using complementarity determining region (CDR)3 polymerase chain reaction (PCR) in 12 leukemias at both diagnosis and relapse indicates that this instability may increase as a function of time. In only one of seven cases in which relapse occurred within 3 years from diagnosis was a new VHDJH joining identified and this coexisted with the original diagnostic joining. Most strikingly, new VHDJH joinings were identified in four of five cases in which relapse occurred more than 5 years from diagnosis. In this latter population, the instability of the joinings was generated from VH----VH gene replacement events in two cases, since the new joinings retained the original DJH sequences and partial N region homology at the VHD junction, and probably in a third case from a VH gene rearrangement to a common DJH precursor. Furthermore, in five of 23 (21.7%) additional cases studied at diagnosis, subclones were identified that had similar modifications of the VH-N region. These data indicate that VH gene replacement events and VH gene rearrangements to a common DJH joining contribute to the instability of the VHDJH joining in ALL. This phenomenon should be taken into consideration in those methodologies that exploit IgH rearrangements for detection of minimal residual disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1728310

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

1.  The study of minimal residual disease in acute lymphoblastic leukaemia.

Authors:  C J Knechtli; N J Goulden; K Langlands; M N Potter
Journal:  Clin Mol Pathol       Date:  1995-04

2.  Quantitative analysis of minimal residual disease predicts relapse in children with B-lineage acute lymphoblastic leukemia in DFCI ALL Consortium Protocol 95-01.

Authors:  Jianbiao Zhou; Meredith A Goldwasser; Aihong Li; Suzanne E Dahlberg; Donna Neuberg; Hongjun Wang; Virginia Dalton; Kathryn D McBride; Stephen E Sallan; Lewis B Silverman; John G Gribben
Journal:  Blood       Date:  2007-05-07       Impact factor: 22.113

Review 3.  V(H) replacement in rearranged immunoglobulin genes.

Authors:  John M Darlow; David I Stott
Journal:  Immunology       Date:  2005-02       Impact factor: 7.397

4.  Gene conversion in human rearranged immunoglobulin genes.

Authors:  John M Darlow; David I Stott
Journal:  Immunogenetics       Date:  2006-05-17       Impact factor: 2.846

5.  Immunoglobulin gene sequence analysis to further assess B-cell origin of multiple myeloma.

Authors:  D D Biggs; P Kraj; J Goldman; L Jefferies; C Carchidi; K Anderson; L E Silberstein
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

6.  Kinetics of minimal residual disease during induction/consolidation therapy in standard-risk adult B-lineage acute lymphoblastic leukemia.

Authors:  C Scholten; M Födinger; M Mitterbauer; K Laczika; G Mitterbauer; O A Haas; P Knöbl; I Schwarzinger; R Thalhammer; B Purtscher
Journal:  Ann Hematol       Date:  1995-10       Impact factor: 3.673

7.  Rearranged patterns of IgH and TcR gamma genes in patients with acute lymphoblastic leukemia.

Authors:  S Li; B Wang; C Li
Journal:  J Tongji Med Univ       Date:  1997

Review 8.  Immunoglobulin variable region structure and B-cell malignancies.

Authors:  H Kiyoi; T Naoe
Journal:  Int J Hematol       Date:  2001-01       Impact factor: 2.319

9.  Gene rearrangement study for minimal residual disease monitoring in children with acute lymphocytic leukemia.

Authors:  Juliana Godoy Assumpção; Francisco Danilo Ferreira Paula; Sandra Guerra Xavier; Mitiko Murao; Joaquim Caetano de Aguirre; Alvaro Pimenta Dutra; Eduardo Ribeiro Lima; Benigna Maria de Oliveira; Marcos Borato Viana
Journal:  Rev Bras Hematol Hemoter       Date:  2013

10.  Predominance of fetal type DJH joining in young children with B precursor lymphoblastic leukemia as evidence for an in utero transforming event.

Authors:  R Wasserman; N Galili; Y Ito; B A Reichard; S Shane; G Rovera
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.